Affirms 2023 sales outlook of at least $2.05B, consensus $2.06B.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on QGEN:
- QIAGEN welcomes U.S. Preventive Services Task Force reaffirmation for latent TB screening in populations at increased risk
- QIAGEN launches QIAstat-Dx in Japan with respiratory panel for syndromic testing
- QIAGEN announces expansion of Supervisory Board
- QIAGEN showcases latest technologies to advance cancer research at AACR Annual Meeting 2023
- Qiagen receives approval for its net-zero carbon emissions target by SBTi